Page last updated: 2024-11-07

prednisone and Non-alcoholic Fatty Liver Disease

prednisone has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, M1
Hori, T1
Igarashi, K1
Iesato, K1
Saito, M1
Miyanishi, K1
Kikuchi, N1
Fujita, H1
Tsutsumi, H1
Moseley, RH1
Manoogian, B1
Shehab, T1
Saint, S1

Other Studies

2 other studies available for prednisone and Non-alcoholic Fatty Liver Disease

ArticleYear
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma

2018
Clinical problem-solving. An intricate interplay.
    The New England journal of medicine, 2012, Oct-04, Volume: 367, Issue:14

    Topics: alpha 1-Antitrypsin; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Diagnosis, Differential

2012